Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
Authors
Keywords
-
Journal
DRUG SAFETY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-17
DOI
10.1007/s40264-021-01109-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antidepressants- and antipsychotics-induced hepatotoxicity
- (2021) Nevena Todorović Vukotić et al. ARCHIVES OF TOXICOLOGY
- If DILI Is Suspected, Don’t Dally
- (2021) Aamer Abbass et al. DIGESTIVE DISEASES AND SCIENCES
- Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans
- (2021) Heather P Llewellyn et al. TOXICOLOGICAL SCIENCES
- Liraglutide-Induced Hepatotoxicity
- (2021) Yaakov Maor et al. Biomedicines
- Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet?
- (2021) Junya Shiota et al. HEPATOLOGY
- Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
- (2021) Harshad Devarbhavi et al. Hepatology International
- Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
- (2021) Rolf Teschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fatal liver failure after therapeutic doses of paracetamol in a patient with Duchenne muscular dystrophy and atypical pharmacogenetic profile of drug‐metabolizing enzymes
- (2020) Yvonne Elisabeth Lao et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Metamizole: An underrated agent causing severe idiosyncratic drug‐induced liver injury
- (2020) Marcial Sebode et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation
- (2020) Huaxia Yang et al. CLINICAL IMMUNOLOGY
- Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record
- (2020) Amoah Yeboah-Korang et al. DRUG SAFETY
- Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs
- (2020) Lisa A. Ronald et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Anti‐PD1‐Induced Immune‐Related Adverse Events and Survival Outcomes in Advanced Melanoma
- (2020) Aleksi Suo et al. ONCOLOGIST
- The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature
- (2020) Vivek Kumar et al. ONCOLOGIST
- Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey
- (2020) Robert A. Mitchell et al. PLoS One
- Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701
- (2020) Mónica Teixeira et al. Revista da Associacao Medica Brasileira
- Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
- (2020) Takumi Onoyama et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
- (2020) Siyu Fu et al. Frontiers in Pharmacology
- Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury
- (2020) Shou-yan Wu et al. ACTA PHARMACOLOGICA SINICA
- Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury
- (2020) Jiaxi Zhao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Liver injury associated with the analgetic drug metamizole
- (2020) Einar S. Björnsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Fatal acetaminophen poisoning with hepatic microvesicular steatosis in a child after repeated administration of therapeutic doses
- (2020) Renaud Bouvet et al. FORENSIC SCIENCE INTERNATIONAL
- Hepatotoxicity from Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation
- (2020) Thoetchai (Bee) Peeraphatdit et al. HEPATOLOGY
- HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury
- (2020) Yi-Ju Li et al. HEPATOLOGY
- Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies
- (2020) Mohammad Parohan et al. HEPATOLOGY RESEARCH
- Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population
- (2020) Bilin Tao et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- COVID-19: Abnormal liver function tests
- (2020) Qingxian Cai et al. JOURNAL OF HEPATOLOGY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Immune‐related hepatitis related to checkpoint inhibitors: clinical and prognostic factors
- (2020) Mar Riveiro‐Barciela et al. LIVER INTERNATIONAL
- Liver injury during highly pathogenic human coronavirus infections
- (2020) Ling Xu et al. LIVER INTERNATIONAL
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments
- (2020) Shelli Schomaker et al. PLoS One
- Acute liver failure requiring transplantation caused by ulipristal acetate
- (2020) Lucy Meunier et al. Clinics and Research in Hepatology and Gastroenterology
- Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
- (2020) Wanvisa Udomsinprasert et al. Scientific Reports
- Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift®)
- (2020) Sebastian Michels et al. Multiple Sclerosis and Related Disorders
- Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury
- (2020) Marwan Ghabril et al. Clinical and Translational Gastroenterology
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
- (2020) Charles Dolladille et al. JAMA Oncology
- Implications of COVID-19 for patients with pre-existing digestive diseases
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature
- (2020) Farah Khorassani et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity
- (2020) James H. Lewis et al. DRUG SAFETY
- Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
- (2020) Xiaodi Guo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- COVID-19 and Liver
- (2020) Dinesh Jothimani et al. JOURNAL OF HEPATOLOGY
- Liver injury caused by oral anticoagulants: A population‐based retrospective cohort study
- (2020) Helgi K. Björnsson et al. LIVER INTERNATIONAL
- First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19
- (2020) Damir Muhović et al. LIVER INTERNATIONAL
- Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
- (2020) Spinello Antinori et al. PHARMACOLOGICAL RESEARCH
- Mechanistic Investigations Support Liver Safety of Ubrogepant
- (2020) Brenda Smith et al. TOXICOLOGICAL SCIENCES
- Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)
- (2020) Lixin Ke et al. Frontiers in Pharmacology
- Drug induced liver injury: an update
- (2020) Miren Garcia-Cortes et al. ARCHIVES OF TOXICOLOGY
- Outcomes after resumption of immune checkpoint inhibitor therapy after high‐grade immune‐mediated hepatitis
- (2020) Michael Li et al. CANCER
- A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury
- (2020) Muhammed S Moosa et al. CLINICAL INFECTIOUS DISEASES
- Economic Evaluation of Screening Interventions for Drug Induced Liver Injury
- (2020) Saundria Moed et al. CLINICAL INFECTIOUS DISEASES
- Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians
- (2020) Camille Houron et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD
- (2020) James H. Lewis et al. CTS-Clinical and Translational Science
- High-Fidelity Drug Induced Liver Injury Screen Using Human PSC-derived Organoids
- (2020) Tadahiro Shinozawa et al. GASTROENTEROLOGY
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nilotinib-induced liver injury
- (2020) Youwen Tan et al. MEDICINE
- Polygenic architecture informs potential vulnerability to drug-induced liver injury
- (2020) Masaru Koido et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series
- (2020) Chancey Carothers et al. PHARMACOTHERAPY
- Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial
- (2020) Joung Youp Shin et al. PLoS One
- Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse
- (2020) Rachel J. Church et al. PLoS One
- (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis
- (2020) Min Wang et al. Cell Death & Disease
- Genetic Risk Factors in Drug‐Induced Liver Injury Due to Isoniazid‐Containing Antituberculosis Drug Regimens
- (2020) Paola Nicoletti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Liver disease and COVID‐19: from Pathogenesis to Clinical Care
- (2020) Antonio Saviano et al. HEPATOLOGY
- Analysis of Risk Factors for Hepatotoxicity Induced by Immune Checkpoint Inhibitors
- (2020) Young Ah Cho et al. JOURNAL OF IMMUNOTHERAPY
- Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
- (2020) James H. Lewis et al. ONCOLOGIST
- Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy
- (2020) Deepa Chand et al. JOURNAL OF HEPATOLOGY
- Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials
- (2020) Hao Niu et al. PHARMACOLOGICAL RESEARCH
- Next Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
- (2019) Sharin E. Roth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids
- (2019) Seon Ju Mun et al. JOURNAL OF HEPATOLOGY
- Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
- (2019) Gaby Danan et al. Frontiers in Pharmacology
- CDK 4/6 inhibitor successful rechallenge after limiting hepatic toxicity
- (2019) Lucie Meynard et al. Breast Journal
- Fenofibrate‐induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database
- (2019) Shizhan Ma et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis
- (2019) Wimonchat Tangamornsuksan et al. PHARMACOGENOMICS JOURNAL
- Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors
- (2019) Ethan D. Miller et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil
- (2019) Carolline Araujo-Mariz et al. Annals of Hepatology
- Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
- (2019) Caitlin Mullins et al. ANNALS OF PHARMACOTHERAPY
- Non‐alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor
- (2019) Koji Sawada et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Early Acetaminophen-Protein Adducts Predict Hepatotoxicity Following Overdose
- (2019) Angela L. Chiew et al. JOURNAL OF HEPATOLOGY
- Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics
- (2019) Prabhavathi Fernandes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reproducing human and cross-species drug toxicities using a Liver-Chip
- (2019) Kyung-Jin Jang et al. Science Translational Medicine
- Genetic Predisposition to Drug-Induced Liver Injury
- (2019) Camilla Stephens et al. Clinics in Liver Disease
- The role of NAT2 polymorphism and methylation in anti‐tuberculosis drug‐induced liver injury in Mongolian tuberculosis patients
- (2019) Dong Zhang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Sclerosing Cholangitis Like Changes on Magnetic Resonance Cholangiography in Patients with Drug Induced Liver Injury
- (2018) Jawad Ahmad et al. Clinical Gastroenterology and Hepatology
- Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
- (2018) Eleonora De Martin et al. JOURNAL OF HEPATOLOGY
- Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital
- (2018) Natalie Woodhead et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
- (2018) Dick Menzies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Latest advances in diagnosing and predicting DILI: what was new in 2017?
- (2018) Michele S. Barnhill et al. Expert Review of Gastroenterology & Hepatology
- A Rapid Method to Estimate Hepatocyte Loss Due to Drug-Induced Liver Injury
- (2018) Jae-Yong Chung et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug-Induced Liver Injury: Highlights of the Recent Literature
- (2018) Mark Real et al. DRUG SAFETY
- Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?
- (2018) Mar Riveiro-Barciela et al. JOURNAL OF HEPATOLOGY
- Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins
- (2017) Iris Spänkuch et al. EUROPEAN JOURNAL OF CANCER
- Ulipristal acetate as a treatment option for uterine fibroids
- (2017) Karolina Piecak et al. Przeglad Menopauzalny
- Drug-induced liver injury due to antibiotics
- (2017) Einar S. Björnsson SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mechanism of isoniazid-induced hepatotoxicity: then and now
- (2016) Imir Metushi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series
- (2016) Lavinia Spain et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab
- (2016) Ryota Tanaka et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Sequential immunotherapy regimens—expect the unexpected
- (2016) Patricio Serra-Bellver et al. LANCET ONCOLOGY
- Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity
- (2015) Paul H. Hayashi et al. Clinical Gastroenterology and Hepatology
- Secondary sclerosing cholangitis in patients with drug-induced liver injury
- (2015) Hafsteinn O. Gudnason et al. DIGESTIVE AND LIVER DISEASE
- Hepatotoxicity of New Oral Anticoagulants (NOACs)
- (2015) Evangelia Liakoni et al. DRUG SAFETY
- Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis
- (2015) Jeffrey Cohen et al. JAMA Neurology
- Liraglutide-Induced Autoimmune Hepatitis
- (2014) Emily Kern et al. JAMA Internal Medicine
- Antidepressant-Induced Liver Injury: A Review for Clinicians
- (2013) Cosmin Sebastian Voican et al. AMERICAN JOURNAL OF PSYCHIATRY
- Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
- (2013) W. Jonat et al. ANNALS OF ONCOLOGY
- Liquorice, a unique “guide drug” of traditional Chinese medicine: A review of its role in drug interactions
- (2013) Xiaoying Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
- (2013) Matthew J Armstrong et al. BMJ Open
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma
- (2012) David E. Kleiner et al. DIGESTIVE DISEASES AND SCIENCES
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
- (2011) Michael B. Sporn et al. JOURNAL OF NATURAL PRODUCTS
- Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure
- (2010) Niraj Khandelwal et al. HEPATOLOGY
- Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension
- (2009) Jiri Ceral et al. BLOOD PRESSURE
- Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure
- (2009) L. P. James et al. DRUG METABOLISM AND DISPOSITION
- CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes
- (2009) Scott A. Reisman et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Acetaminophen-Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose
- (2008) LP James et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic or Pharmacologic Amplification of Nrf2 Signaling Inhibits Acute Inflammatory Liver Injury in Mice
- (2008) William O. Osburn et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now